Entity Type
Company
Role
10%+ Owner
Stock Symbol
ALPN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Decheng Capital China Life Sciences USD Fund III, L.P. since 7/7/2023

Holdings reported by Decheng Capital China Life Sciences USD Fund III, L.P. for Alpine Immune Sciences, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 6,582,380 $83.9 M $12.74 Jan 18, 2024 Direct
Warrant (right to buy) 0 Jan 18, 2024 Direct Common Stock

Transactions reported by Decheng Capital China Life Sciences USD Fund III, L.P. for Alpine Immune Sciences, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership